Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 256 followers
Latest posts
Last updated about 15 hours ago
Human medicines European public assessment report (EPAR): Gavreto, pralsetinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Withdrawn (authorisation)
about 15 hours ago
Human medicines European public assessment report (EPAR): Gavreto, pralsetinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Date of authorisation: 13/12/2024, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Date of authorisation...
Regulation (EU) 2024/568: Questions and answers clinic for the Human Industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2025, 11:00 (CET) to 10 February 2025, 12:00 (CET)
about 16 hours ago
Regulation (EU) 2024/568: Questions and answers clinic for the Human Industry stakeholders...
Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 5, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of...
Opening procedures at EMA to non-EU authorities (OPEN) framework
about 16 hours ago
Opening procedures at EMA to non-EU authorities (OPEN) framework
Opening procedures at EMA to non-EU authorities (OPEN) initiative
about 16 hours ago
Opening procedures at EMA to non-EU authorities (OPEN) initiative
Human medicines European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Date of authorisation: 16/12/1998, Revision: 30, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim...